Fisetin-metformin co-loaded in mesoporous silica nanoparticles (MSNs) inhibited triple negative breast cancer proliferation

Objective(s): Herbal compounds with cytotoxicity have been of great interest in recent years to improve cancer treatment methods. Fisetin is an anti-cancer herbal compound with low solubility in aqueous systems. Metformin is another compound with anti-cancer effects. In this study, the combined effe...

Full description

Bibliographic Details
Main Authors: Mohammad Reza Karimzadeh, Mahshid Samie Ghahfarokhi, Razieh Heidari, Somayeh Reiisi
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2023-10-01
Series:Nanomedicine Journal
Subjects:
Online Access:https://nmj.mums.ac.ir/article_23121_9d77ebed4a2c02f10018e0bcc5d4e557.pdf
_version_ 1797421329548312576
author Mohammad Reza Karimzadeh
Mahshid Samie Ghahfarokhi
Razieh Heidari
Somayeh Reiisi
author_facet Mohammad Reza Karimzadeh
Mahshid Samie Ghahfarokhi
Razieh Heidari
Somayeh Reiisi
author_sort Mohammad Reza Karimzadeh
collection DOAJ
description Objective(s): Herbal compounds with cytotoxicity have been of great interest in recent years to improve cancer treatment methods. Fisetin is an anti-cancer herbal compound with low solubility in aqueous systems. Metformin is another compound with anti-cancer effects. In this study, the combined effect of fisetin and metformin was investigated using mesoporous silica nanoparticles (MSNs) in breast cancer cell lines. Materials and Methods: After the synthesis of nanoparticles, they were characterized using XRD, TEM, SEM. The DLS test showed a size of 143.4 nm with zeta-potential -39.1 mV. Fisetin and metformin were loaded into nanoparticles and loading was confirmed by FTIR. The toxicity of different concentrations of free drug (metformin, fisetin, fisetin-metformin) and Nanoformulations (metformin, fisetin and nano-fisetin-metformin) was investigated on two breast cancer lines MCF7 and MDA-MB-231. Results: Fisetin-metformin co-loaded in MSNs showed the highest cytotoxicity among all formulations in both cell lines. The inhibition of colony formation and migration rate was effectively observed in the co-treatment of cells with fisetin and metformin loaded in nanoparticles compared to single treatments. The expression of tumor suppressor miR-200b-3p and miR-34a-5p showed that fisetin increased the expression of these tumor suppressors compared to the control. Conclusion: The anti-cancer effect of fisetin-metformin in combination increased the expression of tumor suppressors due to the regulation of a wide range of gene network involving in cancer progress. The obtained results highlight the use of MSN as an effective drug delivery system for simultaneous delivery of herbal cytotoxic compounds in cancer.
first_indexed 2024-03-09T07:15:36Z
format Article
id doaj.art-7b5f2bff9a194f20a6ea7f83868991e3
institution Directory Open Access Journal
issn 2322-3049
2322-5904
language English
last_indexed 2024-03-09T07:15:36Z
publishDate 2023-10-01
publisher Mashhad University of Medical Sciences
record_format Article
series Nanomedicine Journal
spelling doaj.art-7b5f2bff9a194f20a6ea7f83868991e32023-12-03T08:35:41ZengMashhad University of Medical SciencesNanomedicine Journal2322-30492322-59042023-10-0110429330310.22038/nmj.2023.73702.179623121Fisetin-metformin co-loaded in mesoporous silica nanoparticles (MSNs) inhibited triple negative breast cancer proliferationMohammad Reza Karimzadeh0Mahshid Samie Ghahfarokhi1Razieh Heidari2Somayeh Reiisi3Department of Medical Genetics, School of Medicine, Bam University of Medical Sciences, Bam, IranDepartment of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, IranDepartment of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, IranDepartment of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, IranObjective(s): Herbal compounds with cytotoxicity have been of great interest in recent years to improve cancer treatment methods. Fisetin is an anti-cancer herbal compound with low solubility in aqueous systems. Metformin is another compound with anti-cancer effects. In this study, the combined effect of fisetin and metformin was investigated using mesoporous silica nanoparticles (MSNs) in breast cancer cell lines. Materials and Methods: After the synthesis of nanoparticles, they were characterized using XRD, TEM, SEM. The DLS test showed a size of 143.4 nm with zeta-potential -39.1 mV. Fisetin and metformin were loaded into nanoparticles and loading was confirmed by FTIR. The toxicity of different concentrations of free drug (metformin, fisetin, fisetin-metformin) and Nanoformulations (metformin, fisetin and nano-fisetin-metformin) was investigated on two breast cancer lines MCF7 and MDA-MB-231. Results: Fisetin-metformin co-loaded in MSNs showed the highest cytotoxicity among all formulations in both cell lines. The inhibition of colony formation and migration rate was effectively observed in the co-treatment of cells with fisetin and metformin loaded in nanoparticles compared to single treatments. The expression of tumor suppressor miR-200b-3p and miR-34a-5p showed that fisetin increased the expression of these tumor suppressors compared to the control. Conclusion: The anti-cancer effect of fisetin-metformin in combination increased the expression of tumor suppressors due to the regulation of a wide range of gene network involving in cancer progress. The obtained results highlight the use of MSN as an effective drug delivery system for simultaneous delivery of herbal cytotoxic compounds in cancer.https://nmj.mums.ac.ir/article_23121_9d77ebed4a2c02f10018e0bcc5d4e557.pdfbreast cancerdrug delivery systemsflavonolsmetforminnanoparticles
spellingShingle Mohammad Reza Karimzadeh
Mahshid Samie Ghahfarokhi
Razieh Heidari
Somayeh Reiisi
Fisetin-metformin co-loaded in mesoporous silica nanoparticles (MSNs) inhibited triple negative breast cancer proliferation
Nanomedicine Journal
breast cancer
drug delivery systems
flavonols
metformin
nanoparticles
title Fisetin-metformin co-loaded in mesoporous silica nanoparticles (MSNs) inhibited triple negative breast cancer proliferation
title_full Fisetin-metformin co-loaded in mesoporous silica nanoparticles (MSNs) inhibited triple negative breast cancer proliferation
title_fullStr Fisetin-metformin co-loaded in mesoporous silica nanoparticles (MSNs) inhibited triple negative breast cancer proliferation
title_full_unstemmed Fisetin-metformin co-loaded in mesoporous silica nanoparticles (MSNs) inhibited triple negative breast cancer proliferation
title_short Fisetin-metformin co-loaded in mesoporous silica nanoparticles (MSNs) inhibited triple negative breast cancer proliferation
title_sort fisetin metformin co loaded in mesoporous silica nanoparticles msns inhibited triple negative breast cancer proliferation
topic breast cancer
drug delivery systems
flavonols
metformin
nanoparticles
url https://nmj.mums.ac.ir/article_23121_9d77ebed4a2c02f10018e0bcc5d4e557.pdf
work_keys_str_mv AT mohammadrezakarimzadeh fisetinmetformincoloadedinmesoporoussilicananoparticlesmsnsinhibitedtriplenegativebreastcancerproliferation
AT mahshidsamieghahfarokhi fisetinmetformincoloadedinmesoporoussilicananoparticlesmsnsinhibitedtriplenegativebreastcancerproliferation
AT raziehheidari fisetinmetformincoloadedinmesoporoussilicananoparticlesmsnsinhibitedtriplenegativebreastcancerproliferation
AT somayehreiisi fisetinmetformincoloadedinmesoporoussilicananoparticlesmsnsinhibitedtriplenegativebreastcancerproliferation